Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback